Supplemental Figure S3 from Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

Julia K. Rotow,Philippe Gui,Wei Wu,Victoria M. Raymond,Richard B. Lanman,Frederic J. Kaye,Nir Peled,Ferran Fece de la Cruz,Brandon Nadres,Ryan B. Corcoran,Iwei Yeh,Boris C. Bastian,Petr Starostik,Kimberly Newsom,Victor R. Olivas,Alexander M. Wolff,James S. Fraser,Eric A. Collisson,Caroline E. McCoach,D. Ross Camidge,Jose Pacheco,Lyudmila Bazhenova,Tianhong Li,Trever G. Bivona,Collin M. Blakely

openalex（2023）

Cited 0|Views41
No score
Abstract
MET tyrosine kinase domain modeling location of the F1200 residue
More
Translated text
Key words
MET Signaling
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined